Anti-TNFalpha therapy in a rare case of Crohn's disease: still a panacea.
Verburg
Robert
R
Zelissen
Pierre
P
Rothova
Aniki
A
Siersema
Peter D
PD
Oldenburg
Bas
B
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D004351:Drug Resistance; D006801:Humans; D000069285:Infliximab; D008297:Male; D010211:Papilledema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014605:Uveitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab